Headline News about Maxcyte Inc
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/11/groupon_-_logo_0.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Recap: MaxCyte Q1 Earnings
May 10, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Looking Into MaxCyte's Return On Capital Employed
March 16, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
MaxCyte's Earnings: A Preview
March 14, 2023
Via Benzinga
MaxCyte Earnings Perspective: Return On Capital Employed
December 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/11/disney_-logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://investorplace.com/wp-content/uploads/2021/08/penny-stocks-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2020/06/death-stocks-to-sell.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/04/13/aapharma_1.png?width=1200&height=800&fit=crop)
MaxCyte Expects Q1 Sales To Beat Expectations, CFO Resigns
April 13, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_2109.jpeg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_170.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_6062.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/28/aapharma_13.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8343.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_4525.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/13/lab-5740505_1920.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_5836.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/roce_image_786.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2958.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_1335.jpeg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_4887.jpeg?width=720)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
MaxCyte, Inc. (MXCT) Q3 2021 Earnings Call Transcript
November 12, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_329.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_4213.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_3607.jpeg)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.